This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Ikeda, T Articles by Furukawa, F Search for Related Content PubMed PubMed Citation Articles by Ikeda, T Articles by Furukawa, F Social Bookmarking                         What's this?

The effects of vitamin A derivative etretinate on the skin of MRL mice

Department of Dermatology, Wakayama Medical University, Wakayama, Japan, t-ikeda{at}wakayama-med.ac.jp

T Nishide

Department of Dermatology, Wakayama Medical University, Wakayama, Japan

T Ohtani

Department of Dermatology, Wakayama Medical University, Wakayama, Japan

F Furukawa

Department of Dermatology, Wakayama Medical University, Wakayama, Japan

MRL/Mp-lpr/lpr (MRL/lpr) mice are characterized by the disorder of apoptosis due to defects in Fas antigens and autoimmune symptoms including spontaneous lupus erythematosus (LE)-like skin lesions. MRL/Mp- +/+ (MRL/n) mice do not carry the defect of lpr mutation nor do they exhibit skin disorders during the first six months of life. Retinoids are known to inhibit the proliferation of skin fibroblasts, collagen synthesis, modulate immune responses, and apoptosis by Fas ligand upregulation in skin fibroblasts. We examined changes in dermal thickness and appearance of skin disorders in five months old MRL/lpr mice by oral treatment with etretinate, a retinoic acid derivative. Etretinate treated MRL/lpr mice did not have skin lesions or dermatopathological characteristics including an increase in cells infiltrating the dermis. The mean dermal thickness of MRL/lpr and MRL/n mice treated with etretinate decreased significantly and apoptotic cells density in the dermis of MRL/lpr mice with etretinate was significantly higher compared with the control group (P, 0.05) although MRL/lpr mice have a defect within the Fas antigen. We assumed that etretinate reduced dermal thickness, and suppressed the appearance of skin lesions by inducting apoptosis and perhaps regulation of cytokine expression.

Key Words: apoptosis • etretinate • MRL • skin lesion

Lupus, Vol. 14, No. 7, 510-516 (2005)
DOI: 10.1191/0961203305lu2144oa


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?